Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Search

Search Results for novartis

India annuls patent of Novartis cardiac drug Vymada
News

India annuls patent of Novartis' heart disease drug Vymada

The patent officer cited lack of novelty, insufficient inventive step, and inadequate disclosure of advantages in the patent application as reasons